WASHC1
gene geneOn this page
Also known as FLJ00038
Summary
WASHC1 (WASH complex subunit 1, HGNC:24361) is a protein-coding gene on chromosome 9p24.3, encoding WASH complex subunit 1 (A8K0Z3). Acts as a component of the WASH core complex that functions as a nucleation-promoting factor (NPF) at the surface of endosomes, where it recruits and activates the Arp2/3 complex to induce actin polymerization, playing a key role in the fission of tubules that serve as transport…. It is a common-essential gene (DepMap: required in 100.0% of cancer cell lines).
Enables alpha-tubulin binding activity and ubiquitin protein ligase binding activity. Involved in several processes, including Arp2/3 complex-mediated actin nucleation; endosomal transport; and positive regulation of pseudopodium assembly. Located in several cellular components, including endosome; exocyst; and lamellipodium. Part of WASH complex.
Source: NCBI Gene 100287171 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 100 total
- Cancer dependency (DepMap): dependent in 100.0% of screened cell lines (common-essential)
- MANE Select transcript:
NM_001378090
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24361 |
| Approved symbol | WASHC1 |
| Name | WASH complex subunit 1 |
| Location | 9p24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ00038 |
| Ensembl gene | ENSG00000181404 |
| Ensembl biotype | protein_coding |
| OMIM | 613632 |
| Entrez | 100287171 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 3 protein_coding, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000442898, ENST00000642633, ENST00000696149, ENST00000696150, ENST00000696151
RefSeq mRNA: 2 — MANE Select: NM_001378090
NM_001378090, NM_182905
CCDS: CCDS78375
Canonical transcript exons
ENST00000696149 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001676789 | 16965 | 17166 |
| ENSE00001712759 | 18381 | 18492 |
| ENSE00001724555 | 24851 | 25004 |
| ENSE00003482868 | 15909 | 16061 |
| ENSE00003492298 | 17344 | 17479 |
| ENSE00003498112 | 17719 | 17855 |
| ENSE00003568262 | 18028 | 18174 |
| ENSE00003573188 | 16718 | 16876 |
| ENSE00003680292 | 15081 | 15149 |
| ENSE00003966203 | 14513 | 14940 |
| ENSE00003966204 | 29312 | 29456 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 90.55.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left uterine tube | UBERON:0001303 | 90.55 | gold quality |
| lower esophagus | UBERON:0013473 | 90.38 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 90.38 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 90.06 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 89.83 | gold quality |
| apex of heart | UBERON:0002098 | 89.43 | gold quality |
| body of uterus | UBERON:0009853 | 89.27 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 89.07 | gold quality |
| myometrium | UBERON:0001296 | 88.99 | gold quality |
| right uterine tube | UBERON:0001302 | 88.16 | gold quality |
| spleen | UBERON:0002106 | 87.75 | gold quality |
| skin of leg | UBERON:0001511 | 87.60 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 87.54 | gold quality |
| endocervix | UBERON:0000458 | 87.53 | gold quality |
| fundus of stomach | UBERON:0001160 | 87.49 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 87.48 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 87.42 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 87.19 | gold quality |
| esophagus | UBERON:0001043 | 87.08 | gold quality |
| fallopian tube | UBERON:0003889 | 87.06 | gold quality |
| zone of skin | UBERON:0000014 | 87.04 | gold quality |
| vagina | UBERON:0000996 | 87.04 | gold quality |
| gastrocnemius | UBERON:0001388 | 87.00 | gold quality |
| cerebellum | UBERON:0002037 | 86.87 | gold quality |
| left ovary | UBERON:0002119 | 86.84 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 86.84 | gold quality |
| cerebellar cortex | UBERON:0002129 | 86.82 | gold quality |
| skin of abdomen | UBERON:0001416 | 86.56 | gold quality |
| tibial nerve | UBERON:0001323 | 86.50 | gold quality |
| prostate gland | UBERON:0002367 | 86.49 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.78 |
| E-CURD-10 | no | 17.08 |
| E-GEOD-99795 | no | 12.25 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
14 targeting WASHC1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
| HSA-MIR-1915-3P | 99.58 | 66.79 | 1988 |
| HSA-MIR-671-5P | 99.52 | 67.11 | 1277 |
| HSA-MIR-6877-3P | 98.98 | 65.83 | 560 |
| HSA-MIR-6819-3P | 98.95 | 65.57 | 572 |
| HSA-MIR-767-3P | 98.61 | 67.69 | 1192 |
| HSA-MIR-6887-5P | 98.56 | 68.49 | 1295 |
| HSA-MIR-6795-5P | 98.52 | 68.51 | 1277 |
| HSA-MIR-4277 | 98.34 | 67.17 | 1323 |
| HSA-MIR-5585-5P | 97.95 | 68.80 | 1024 |
| HSA-MIR-6781-3P | 97.44 | 66.85 | 970 |
| HSA-MIR-2682-3P | 97.10 | 66.16 | 840 |
| HSA-MIR-6828-3P | 96.06 | 67.61 | 1155 |
| HSA-MIR-572 | 85.62 | 59.34 | 30 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 100.0% of screened cell lines, common-essential.
Literature-anchored findings (GeneRIF, showing 15)
- WASH exists in a multiprotein complex containing FAM21, which links WASH to endosomes and is required for WASH-dependent retromer-mediated sorting. (PMID:19922874)
- Actin polymerization by WASH influences the shape and maturation of endosomes, and highlights a previously unrecognized role for WASH and the Arp2/3 complex in the degradative steps of endocytic trafficking. (PMID:20175130)
- WASH and Arp2/3 regulates integrin alpha5beta1-mediated invasive cell migration. (PMID:22114305)
- Data show that a component of the WASH regulatory complex (SHRC), FAM21, directly interacts with the retromer CSC protein VPS35. (PMID:22513087)
- WASH and the exocyst complex are required for matrix degradation by an exocytic mechanism that involves tubular connections between MT1-MMP-positive late endosomes and the plasma membrane in contact with the matrix. (PMID:24344185)
- FAM21 not only functions as an integral component of the cytoplasmic WASH complex, but also modulates NF-kappaB gene transcription in the nucleus. (PMID:25431135)
- The WASH-VPEF/FAM21-retromer complexe mediates endosome fission and sorting of virus-containing vesicles prior to virus core uncoating in the cytoplasm. (PMID:26041286)
- Stress-internalized EGFR co-segregates with exogenously expressed pre-melanosomal markers OA1 and fibrillar PMEL, following early endosomal sorting by the actin polymerization-promoting WASH complex (PMID:26066081)
- The USP7 deubiquitinating enzyme is an integral component of the MAGE-L2-TRIM27 ligase and is essential for WASH-mediated endosomal actin assembly and protein recycling. (PMID:26365382)
- WASH has a pivotal role for regulation of NK cell cytotoxicity through Lck-mediated Y141 tyrosine phosphorylation. (PMID:27441653)
- ANKRD50 simultaneously engages multiple parts of the SNX27-retromer-WASH complex machinery in a direct and co-operative interaction network that is needed to efficiently recycle the nutrient transporters. (PMID:27909246)
- Its mutation is not found in a cohort of German patients with sporadic amyotrophic lateral sclerosis and frontotemporal lobar degeneration comorbidity. (PMID:28551275)
- WASH-mediated AHR expression has a critical function in the maintenance of NKp46+ innate lymphoid cells (PMID:28589939)
- In this study, we uncover an alternative role for the ESCRT-0 component hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) in promoting the constitutive recycling of transmembrane proteins. We find that endosomal localization of the actin nucleating factor Wiscott-Aldrich syndrome protein and SCAR homologue (WASH) requires HRS, which occupies adjacent endosomal subdomains (PMID:29891722)
- WASHC1 interacts with MCM2-7 complex to promote cell survival under replication stress. (PMID:35733063)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | wash1 | ENSDARG00000063457 |
| mus_musculus | Washc1 | ENSMUSG00000024101 |
| rattus_norvegicus | Washc1 | ENSRNOG00000053306 |
| drosophila_melanogaster | wash | FBGN0033692 |
| caenorhabditis_elegans | WBGENE00013000 |
Paralogs (1): WASH6P (ENSG00000182484)
Protein
Protein identifiers
WASH complex subunit 1 — A8K0Z3 (reviewed: A8K0Z3)
Alternative names: CXYorf1-like protein on chromosome 9, Protein FAM39E, WAS protein family homolog 1
All UniProt accessions (3): A0A2R8YDD3, A0A8Q3SIH9, A8K0Z3
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a component of the WASH core complex that functions as a nucleation-promoting factor (NPF) at the surface of endosomes, where it recruits and activates the Arp2/3 complex to induce actin polymerization, playing a key role in the fission of tubules that serve as transport intermediates during endosome sorting. Involved in endocytic trafficking of EGF. Involved in transferrin receptor recycling. Regulates the trafficking of endosomal alpha5beta1 integrin to the plasma membrane and involved in invasive cell migration. In T-cells involved in endosome-to-membrane recycling of receptors including T-cell receptor (TCR), CD28 and ITGAL; proposed to be implicated in T cell proliferation and effector function. In dendritic cells involved in endosome-to-membrane recycling of major histocompatibility complex (MHC) class II probably involving retromer and subsequently allowing antigen sampling, loading and presentation during T-cell activation. Involved in Arp2/3 complex-dependent actin assembly driving Salmonella typhimurium invasion independent of ruffling. Involved in the exocytosis of MMP14 leading to matrix remodeling during invasive migration and implicating late endosome-to-plasma membrane tubular connections and cooperation with the exocyst complex. Involved in negative regulation of autophagy independently from its role in endosomal sorting by inhibiting BECN1 ubiquitination to inactivate PIK3C3/Vps34 activity.
Subunit / interactions. Component of the WASH core complex also described as WASH regulatory complex (SHRC) composed of WASH (WASHC1, WASH2P or WASH3P), WASHC2 (WASHC2A or WASHC2C), WASHC3, WASHC4 and WASHC5. The WASH core complex associates via WASHC2 with the F-actin-capping protein dimer (formed by CAPZA1, CAPZA2 or CAPZA3 and CAPZB) in a transient or substoichiometric manner which was initially described as WASH complex. Interacts (via WHD1 region) with WASHC2C; the interaction is direct. Interacts with VPS35; mediates the association with the retromer CSC complex. Interacts with FKBP15. Interacts with alpha-tubulin. Interacts with BECN1; this interaction can be competed out by AMBRA1 binding. Interacts with BLOC1S2; may associate with the BLOC-1 complex. Interacts with tubulin gamma chain (TUBG1 or TUBG2). Interacts with EXOC1, EXOC4, EXOC8; in MMP14-positive endosomes in breast tumor cells; indicative for an association with the exocyst complex. Interacts with TBC1D23.
Subcellular location. Early endosome membrane. Recycling endosome membrane. Late endosome. Cytoplasmic vesicle. Autophagosome. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Centriole.
Post-translational modifications. Ubiquitinated at Lys-220 via ‘Lys-63’-linked ubiquitin chains by the TRIM27:MAGEL2 E3 ubiquitin ligase complex, leading to promote endosomal F-actin assembly.
Domain organisation. The VCA (verprolin, cofilin, acidic) domain promotes actin polymerization by the Arp2/3 complex in vitro.
Miscellaneous. WASH genes duplicated to multiple chromosomal ends during primate evolution, with highest copy number reached in humans, whose WASH repertoires probably vary extensively among individuals. It is therefore difficult to determine which gene is functional or not. The telomeric region of chromosome 9p is paralogous to the pericentromeric regions of chromosome 9 as well as to 2q. Paralogous regions contain 7 transcriptional units. Duplicated WASH genes are also present in the Xq/Yq pseudoautosomal region, as well as on chromosome 1 and 15. The chromosome 16 copy seems to be a pseudogene.
Similarity. Belongs to the WASH1 family.
RefSeq proteins (2): NP_001365019, NP_878908 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR021854 | WASH1_WAHD | Domain |
| IPR028290 | WASH1 | Family |
Pfam: PF11945
UniProt features (30 total): sequence conflict 15, region of interest 6, compositionally biased region 4, mutagenesis site 2, chain 1, domain 1, cross-link 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A8K0Z3-F1 | 66.21 | 0.10 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 220
Mutagenesis-validated functional residues (2):
| Position | Phenotype |
|---|---|
| 220 | abolishes ubiquitination by the trim27:magel2 e3 ubiquitin ligase complex and impairs retrograde transport. |
| 463 | impairs retrograde transport from endosome to golgi apparatus. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 111 (showing top):
GOBP_REGULATION_OF_AUTOPHAGY, GOBP_REGULATION_OF_ACTIN_NUCLEATION, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS, GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGY, GOBP_EXOCYTOSIS, GOBP_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION, GOBP_REGULATION_OF_CATABOLIC_PROCESS, GOBP_ACTIN_FILAMENT_ORGANIZATION, GOBP_SECRETION, GOBP_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION
GO Biological Process (12): exocytosis (GO:0006887), negative regulation of autophagy (GO:0010507), protein transport (GO:0015031), endosomal transport (GO:0016197), extracellular matrix disassembly (GO:0022617), positive regulation of cell migration (GO:0030335), positive regulation of pseudopodium assembly (GO:0031274), regulation of protein ubiquitination (GO:0031396), endocytic recycling (GO:0032456), Arp2/3 complex-mediated actin nucleation (GO:0034314), regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315), retrograde transport, endosome to Golgi (GO:0042147)
GO Molecular Function (6): actin binding (GO:0003779), ubiquitin protein ligase binding (GO:0031625), alpha-tubulin binding (GO:0043014), gamma-tubulin binding (GO:0043015), phosphatidylinositol 3-kinase inhibitor activity (GO:0141039), protein binding (GO:0005515)
GO Cellular Component (15): early endosome (GO:0005769), late endosome (GO:0005770), autophagosome (GO:0005776), centriole (GO:0005814), cytosol (GO:0005829), early endosome membrane (GO:0031901), recycling endosome (GO:0055037), recycling endosome membrane (GO:0055038), WASH complex (GO:0071203), exocyst (GO:0000145), cytoplasm (GO:0005737), endosome (GO:0005768), cytoskeleton (GO:0005856), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| endosome | 3 |
| cytoplasm | 3 |
| cellular anatomical structure | 3 |
| vesicle-mediated transport | 2 |
| endosomal transport | 2 |
| tubulin binding | 2 |
| intracellular membraneless organelle | 2 |
| endosome membrane | 2 |
| secretion by cell | 1 |
| vesicle fusion to plasma membrane | 1 |
| autophagy | 1 |
| negative regulation of catabolic process | 1 |
| regulation of autophagy | 1 |
| transport | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| intracellular transport | 1 |
| cellular component disassembly | 1 |
| extracellular matrix organization | 1 |
| cell migration | 1 |
| regulation of cell migration | 1 |
| positive regulation of cell motility | 1 |
| pseudopodium assembly | 1 |
| regulation of pseudopodium assembly | 1 |
| positive regulation of plasma membrane bounded cell projection assembly | 1 |
| protein ubiquitination | 1 |
| regulation of protein modification by small protein conjugation or removal | 1 |
| vesicle-mediated transport to the plasma membrane | 1 |
| actin nucleation | 1 |
| Arp2/3 complex-mediated actin nucleation | 1 |
| regulation of actin nucleation | 1 |
| intercellular transport | 1 |
| cytosolic transport | 1 |
| cytoskeletal protein binding | 1 |
| ubiquitin-like protein ligase binding | 1 |
| phosphatidylinositol 3-kinase regulator activity | 1 |
| binding | 1 |
| vacuole | 1 |
| microtubule organizing center | 1 |
| early endosome | 1 |
Protein interactions and networks
STRING
552 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| WASHC1 | WASHC3 | Q9Y3C0 | 997 |
| WASHC1 | WASHC5 | Q12768 | 996 |
| WASHC1 | WASHC4 | Q2M389 | 996 |
| WASHC1 | WASHC2C | Q9Y4E1 | 961 |
| WASHC1 | WASHC2A | Q641Q2 | 887 |
| WASHC1 | IGF2R | P11717 | 799 |
| WASHC1 | WAS | P42768 | 754 |
| WASHC1 | SNX27 | Q96L92 | 738 |
| WASHC1 | VPS26A | O75436 | 728 |
| WASHC1 | BLOC1S2 | Q6QNY1 | 693 |
| WASHC1 | VPS35 | Q96QK1 | 670 |
| WASHC1 | CCDC93 | Q567U6 | 658 |
| WASHC1 | VPS29 | Q9UBQ0 | 643 |
| WASHC1 | WASF1 | Q92558 | 629 |
| WASHC1 | SNX1 | Q13596 | 598 |
IntAct
31 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CAPZA2 | CNOT1 | psi-mi:“MI:0914”(association) | 0.640 |
| CAPZB | CNOT1 | psi-mi:“MI:0914”(association) | 0.640 |
| EXOC8 | WASHC1 | psi-mi:“MI:2364”(proximity) | 0.550 |
| EXOC8 | WASHC1 | psi-mi:“MI:0915”(physical association) | 0.550 |
| EXOC1 | WASHC1 | psi-mi:“MI:0915”(physical association) | 0.510 |
| BECN1 | WASHC1 | psi-mi:“MI:0915”(physical association) | 0.460 |
| WASHC1 | BECN1 | psi-mi:“MI:0915”(physical association) | 0.460 |
| BECN1 | WASHC1 | psi-mi:“MI:0403”(colocalization) | 0.460 |
| FKBP15 | WASHC1 | psi-mi:“MI:0403”(colocalization) | 0.430 |
| WASHC1 | EXOC4 | psi-mi:“MI:0915”(physical association) | 0.400 |
| WASHC1 | CTTN | psi-mi:“MI:0403”(colocalization) | 0.380 |
| CTTN | WASHC1 | psi-mi:“MI:0403”(colocalization) | 0.380 |
| WASHC1 | CTTN | psi-mi:“MI:2364”(proximity) | 0.380 |
| Vps29 | WASHC1 | psi-mi:“MI:0914”(association) | 0.350 |
| WASHC5 | WASHC1 | psi-mi:“MI:0914”(association) | 0.350 |
| VPS35 | WASHC1 | psi-mi:“MI:0914”(association) | 0.350 |
| hspa1a_hspa1b_human-1 | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
| WASHC1 | WASH3P | psi-mi:“MI:0914”(association) | 0.350 |
| WASHC3 | WASHC1 | psi-mi:“MI:0914”(association) | 0.350 |
| Vps35 | WASHC1 | psi-mi:“MI:0914”(association) | 0.350 |
| CEP128 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| CEP152 | CNOT1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| SNX1 | WASHC1 | psi-mi:“MI:0403”(colocalization) | 0.270 |
| WASHC1 | SQSTM1 | psi-mi:“MI:0403”(colocalization) | 0.270 |
| WASHC1 | EXOC1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| WASHC1 | EXOC8 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (102): WASH1 (Proximity Label-MS), WASH1 (Proximity Label-MS), WASH1 (Affinity Capture-Western), WASH1 (Affinity Capture-Western), HGS (Co-localization), EEA1 (Co-localization), WASH1 (Affinity Capture-MS), WASH1 (Affinity Capture-Western), WASH1 (Two-hybrid), WASH1 (Two-hybrid), WASH1 (Two-hybrid), WASH1 (Two-hybrid), WASH1 (Two-hybrid), WASH1 (Two-hybrid), WASH1 (Two-hybrid)
ESM2 similar proteins: A4IG59, A7Z063, A8K0Z3, A8MWX3, B0BN56, B2RYF7, C4AMC7, E7EXT2, F1RCE7, O08719, O18195, O48713, O75061, P70429, P82925, P92204, Q08BD8, Q28DN4, Q28Y46, Q53HL2, Q54CK9, Q54NF8, Q561X3, Q5M8Y7, Q5R896, Q5RBS5, Q5U4A3, Q5XG48, Q5XLR4, Q5ZKA6, Q61733, Q68FU8, Q6AXW0, Q6DD45, Q6VEQ5, Q7JW27, Q7K2D2, Q8BHX3, Q8BYZ1, Q8CH02
Diamond homologs: A4IG59, A7Z063, A8K0Z3, A8MWX3, B2RYF7, C4AMC7, Q28DN4, Q54CK9, Q5U4A3, Q5ZKA6, Q6VEQ5, Q8VDD8, Q9NQA3, Q7JW27, O18195
SIGNOR signaling
3 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| TRIM27 | “up-regulates activity” | WASHC1 | ubiquitination |
| MAGEL2 | “up-regulates activity” | WASHC1 | binding |
| WASHC1 | “form complex” | “WASH complex” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 22 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| regulation of macroautophagy | 5 | 82.1× | 7e-07 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
100 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 81 |
| Likely benign | 9 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2057 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:15904:CTCA:C | donor_loss | 1.0000 |
| 9:15905:TCA:T | donor_loss | 1.0000 |
| 9:15906:CACCT:C | donor_loss | 1.0000 |
| 9:15907:A:AC | donor_gain | 1.0000 |
| 9:15907:ACC:A | donor_loss | 1.0000 |
| 9:15908:C:CA | donor_loss | 1.0000 |
| 9:15908:C:CC | donor_gain | 1.0000 |
| 9:15908:CCTTG:C | donor_gain | 1.0000 |
| 9:16057:CTGGA:C | acceptor_gain | 1.0000 |
| 9:16062:C:CC | acceptor_gain | 1.0000 |
| 9:16069:C:CT | acceptor_gain | 1.0000 |
| 9:16070:G:T | acceptor_gain | 1.0000 |
| 9:16075:G:C | acceptor_gain | 1.0000 |
| 9:16075:G:GC | acceptor_gain | 1.0000 |
| 9:16083:C:CT | acceptor_gain | 1.0000 |
| 9:17163:GGAC:G | acceptor_gain | 1.0000 |
| 9:17164:GAC:G | acceptor_gain | 1.0000 |
| 9:17167:C:CC | acceptor_gain | 1.0000 |
| 9:17171:A:T | acceptor_gain | 1.0000 |
| 9:17175:T:TC | acceptor_gain | 1.0000 |
| 9:17717:A:AC | donor_gain | 1.0000 |
| 9:17718:C:CC | donor_gain | 1.0000 |
| 9:17756:CAGAG:C | donor_gain | 1.0000 |
| 9:17760:G:C | donor_gain | 1.0000 |
| 9:17990:T:TA | donor_gain | 1.0000 |
| 9:24848:CAC:C | donor_loss | 1.0000 |
| 9:24849:ACCT:A | donor_loss | 1.0000 |
| 9:24850:CCTG:C | donor_gain | 1.0000 |
| 9:15079:AC:A | donor_gain | 0.9900 |
| 9:15080:CC:C | donor_gain | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1005686096 (9:27195 G>A), RS1005794586 (9:23634 G>A), RS1007597022 (9:31886 G>C), RS1011539562 (9:14246 G>A,C), RS1013045326 (9:17024 G>C), RS1013430895 (9:23380 G>A,T), RS1015790659 (9:27413 T>C,G), RS1015820456 (9:23666 G>A), RS1017288123 (9:31888 G>A,C), RS1017735987 (9:28185 G>C), RS1022064891 (9:14285 G>C), RS1023116223 (9:23385 G>C), RS1023572411 (9:17032 G>A,C), RS1029982525 (9:28023 A>C), RS1030017185 (9:23708 C>T)
Disease associations
OMIM: gene MIM:613632 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| ICG 001 | increases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Catechin | affects cotreatment, decreases expression | 1 |
| Doxorubicin | affects expression | 1 |
| Tetrachlorodibenzodioxin | affects expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.